Merck's Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected
13th August 2021 Uncategorised 0 Merck’s Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected
nhigginsdunn
Fri, 08/13/2021 – 15:21
More: Merck's Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected
Source: fierce